Among cases of DLBCL, NOS with double-expressor phenotype, the Hans cell-of-origin classification (GCB vs. non-GCB) showed no apparent effect on CD52 expression levels. This evidence concerns the gene CD52 and diffuse large B-cell lymphoma.